Cardiosense, Inc. Completes $15.1M Series A Funding to Advance Artificial Intelligence Platform for Heart Disease
CHICAGO, December 8, 2022 /PRNewswire/ — Cardiosense, Inc., a Chicagoa digital health company based on artificial intelligence and multi-sensor devices to enable early detection of cardiovascular disease, announced today that it has raised $15.1 million in a Series A funding, co-led by Broadview Ventures and Hatteras Venture Partners, with participation from Laerdal Million Lives Fund, …